Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of ILS 22.43 million. The enterprise value is 2.98 million.

Market Cap	22.43M
Enterprise Value	2.98M

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Purple Biotech has 606.09 million shares outstanding. The number of shares has increased by 82.76% in one year.

Current Share Class	606.09M
Shares Outstanding	606.09M
Shares Change (YoY)	+82.76%
Shares Change (QoQ)	+3.95%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	1.85%
Float	599.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.21
P/TBV Ratio	1.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.10

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.00.

Current Ratio	2.88
Quick Ratio	2.70
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.56% and return on invested capital (ROIC) is -11.71%.

Return on Equity (ROE)	-8.56%
Return on Assets (ROA)	-10.27%
Return on Invested Capital (ROIC)	-11.71%
Return on Capital Employed (ROCE)	-17.99%
Revenue Per Employee	n/a
Profits Per Employee	-977,471
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.76% in the last 52 weeks. The beta is -0.58, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y)	-0.58
52-Week Price Change	-73.76%
50-Day Moving Average	4.12
200-Day Moving Average	5.42
Relative Strength Index (RSI)	42.63
Average Volume (20 Days)	1,754,179

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-208,897
Operating Income	-19.51M
Pretax Income	-8.85M
Net Income	-8.80M
EBITDA	-19.41M
EBIT	-19.51M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 19.94 million in cash and 347,038 in debt, giving a net cash position of 19.60 million or 0.03 per share.

Cash & Cash Equivalents	19.94M
Total Debt	347,038
Net Cash	19.60M
Net Cash Per Share	0.03
Equity (Book Value)	107.98M
Book Value Per Share	0.20
Working Capital	13.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -29.75 million and capital expenditures -6,739, giving a free cash flow of -29.76 million.

Operating Cash Flow	-29.75M
Capital Expenditures	-6,739
Free Cash Flow	-29.76M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.76%
Shareholder Yield	n/a
Earnings Yield	-39.23%
FCF Yield	-132.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 6, 2019. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 6, 2019
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	1